New Products and Techniques for Reconstructive Wrist and Elbow Surgery Featured at the American Society for Surgery of the Hand Meeting.

Business Editors/Health/Medical Writers

American Society For Surgery of the Hand Meeting

Booth #209

ARLINGTON, Tenn. & CHICAGO--(BUSINESS WIRE)--Sept. 17, 2003

Physicians to Demonstrate New Injectable Internal Cast to Grow

Bone in Wrists and Preview the First Ceramic Device for Elbow

Replacements in Chicago Sept. 18-20, 2003

Wright Medical Group, Inc. (NASDAQ:WMGI), a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologic materials, today announced that its innovative products for the wrist and elbow will be featured at multiple presentations at the American Society for Surgery of the Hand (ASSH) meeting, being held Sept. 18 to 20, 2003. More than 1,700 hand, orthopaedic, plastic and general surgeons are expected to attend the annual meeting to discuss the latest advances in hand and elbow surgery.

Together, wrist and elbow fractures account for more than 400,000 injuries each year. At the ASSH meeting, Wright's newest product to improve the internal healing of a wrist fracture will be presented, and the company's revolutionary ceramic elbow will be previewed:

    --  Dr. Keith Raskin of the Hospital for Joint Diseases in New
        York will lead a workshop on the MIIG(R) X3 Injectable Graft,
        an injectable internal cast that helps stabilize bone
        fragments internally, and grows bone in wrists that have
        suffered a fracture. The MIIG(R) X3 Injectable Graft is a new
        product available for wrist fractures that dissolves over time
        leaving bone in its place rather than remaining permanently in
        the wrist. Dr. Raskin will review the techniques and benefits
        of treating a wrist fracture both internally with the MIIG(R)
        X3 Injectable Graft and conventional external fixation.

    --  A leading surgeon in elbow replacement, Dr. Graham King of the
        Hand & Upper Limb Centre, St. Joseph Health Centre in London,
        Ontario, will preview the first FDA-cleared ceramic radial
        head, made by Wright. The ceramic material of the joint will
        enable patients to have a longer-lasting and higher
        performance implant. The device is used to treat traumatic
        injuries to the radial head portion of the elbow. About
        100,000 of these injuries occur in the U.S. each year, with
        10-15,000 requiring radial head replacement.

    --  Leading hand surgeons from across the country will gather to
        refine a promising new approach to treating arthritis in the
        carpo-metacarpal or "base of the thumb" joint. Current
        treatments include steroid injection, medication to numb the
        pain, and replacement with silicone or ceramic implants.

        Dr. Scott Steinmann of the Mayo Clinic and renowned
        arthroscopic pioneer Dr. Terry Whipple, Director of
        Orthopaedics and Fitness for American Self of Richmond, Va.,
        will lead discussions for a minimally-invasive procedure to
        restore function to the arthritic thumb joint using a new
        material called GraftJacket(R) Regenerative Tissue Matrix.

About Wright

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and bio-orthopaedic materials. The Company has been in business for more than fifty years and markets its products in over 40 countries worldwide. For more information about Wright, visit our website at www.wmt.com.

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2002), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.